A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction

Clinical trial NCT04284995 · COMPLETED

Trial details

NCT number: NCT04284995
Sponsor: CeleCor Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Disease Myocardial Infarction Heart Diseases Vascular Diseases STEMI - ST Elevation Myocardial Infarction

Start date: 2020-06-02
Primary completion: 2020-11-08
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.